Monday, 11 April 2016

Sun Pharma receives USFDA approval for BromSite and other Top Corporate News of the day

Check out the most important news stories, which captured the headlines at the corporate level in India and internationally. 

Businessman-sitting-on-bench, NewsTata Motors made commercial launch of its new hatchback Tiago in Bihar. The new fuel efficient vehicle would be available at a starting price of Rs 0.33mn (exshowroom) for Revotron 1.2 litre (petrol) and Rs 0.41mn (ex-showroom) in Patna for Revotorq 1.05L (diesel) variant.

Bajaj Auto and its Austrian partner KTM AG are extending their partnership to Indonesia for selling Duke and RC brands of motorcycles of up to 400cc.

As the employee unions oppose stake sale in IDBI Bank, the Government said it is consulting all stakeholders as part of "transformation" of the state-owned lender.

Federal Bank tied up with Phillip Capital (India), a subsidiary of the Singapore headquartered Phillip Capital group, for managing the NRI Portfolio Investment Scheme.

ITC said it has adequate cigarette stocks available in the market despite shutting all its manufacturing in the wake of the government rule that requires larger pictorial warnings on packets.

Cairn India has full indemnity from its former promoter Cairn Energy of UK against levy of any tax for past deeds, including the two-year old Rs 204.95bn retrospective tax demand, its new owner Anil Agarwal has said.

Tata Power said its Singapore-based arm TPIPL has signed an agreement with KS Orka Renewables Pte for sale of its 50 per cent stake in OTP Geothermal Pte (OTP) for USD 30 million.

Sun Pharmaceutical Industries has received approval from the US health regulator for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery. 

No comments:

Post a Comment